tiprankstipranks
Trending News
More News >
Mothercare PLC (GB:MTC)
LSE:MTC

Mothercare (MTC) AI Stock Analysis

Compare
6 Followers

Top Page

GB:MTC

Mothercare

(LSE:MTC)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
1.50 p
▼(-31.51% Downside)
Action:ReiteratedDate:03/20/26
The score is weighed down primarily by very weak financial health (negative equity, declining revenue, and negative operating/free cash flow). Technicals add further pressure given the clear downtrend and negative MACD, while valuation provides limited offset because the negative P/E signals earnings weakness and there is no dividend yield data.
Positive Factors
Niche maternal & baby focus
A focused product niche (maternity, baby, young children) targets an enduring, demographic-driven demand stream. Specialization supports brand recognition, repeat purchases and tailored merchandising, which can sustain revenue resilience as birth-rate driven demand persists.
Relatively stable gross margins
Stable gross margins imply the company maintains pricing power or effective cost control on product procurement. That margin stability provides a structural buffer for returning to profitability if top-line pressures ease and supports investment in product or channel improvements.
Broad product range and channels
A wide product assortment across apparel, nursery and travel equipment plus retail and online distribution reduces single-category risk, enables cross-selling, and supports multi-channel customer reach. This structural diversification aids long-term revenue mix stability.
Negative Factors
Negative shareholders' equity
Negative equity signals severe balance-sheet stress and potential solvency issues. It constrains access to traditional financing, raises creditor risk, and limits strategic flexibility; absent recapitalization, this structural weakness threatens long-term viability and growth options.
Steep, persistent revenue decline
Material, sustained top-line decline reduces scale economies and pressures fixed-cost absorption. Continued revenue contraction undermines operating leverage, hampers reinvestment in product and channels, and raises the risk of market share loss versus better-funded competitors.
Negative operating and free cash flow
Consistent negative operating and free cash flow indicate the business consumes cash to run and grow, necessitating external financing or asset sales. This limits the firm's ability to invest, deleverages resilience to shocks, and increases refinancing and liquidity risk over months.

Mothercare (MTC) vs. iShares MSCI United Kingdom ETF (EWC)

Mothercare Business Overview & Revenue Model

Company DescriptionMothercare plc, through its subsidiaries, operates as a specialist franchisor of products for mothers-to-be and children under the Mothercare brand. The company provides clothing, footwear, home, and travel products, as well as toys. It operates approximately 700 Mothercare stores and 400 additional stores under the Mothercare brand, as well as websites through a network of franchise partners in 37 countries. The company was founded in 1961 and is headquartered in Hemel Hempstead, the United Kingdom.
How the Company Makes Moneynull

Mothercare Financial Statement Overview

Summary
Weak fundamentals overall: income statement shows steep revenue decline (-19.3% most recent year) and inconsistent profitability; balance sheet is highly concerning with negative shareholders’ equity and elevated financial risk; cash flow is pressured with negative operating and free cash flow, indicating sustainability challenges.
Income Statement
45
Neutral
Mothercare's income statement reveals significant challenges. The company has experienced a notable decline in revenue over the years, with a revenue growth rate of -19.3% in the most recent year. Despite a positive net profit margin of 15% in 2021, the company has struggled with profitability, as evidenced by negative net income in previous years. The gross profit margin has been relatively stable, but the declining revenue and inconsistent profitability are concerning.
Balance Sheet
30
Negative
The balance sheet shows a precarious financial position. The company has negative stockholders' equity, indicating potential solvency issues. The debt-to-equity ratio is not meaningful due to negative equity, but the high level of debt relative to assets suggests financial risk. The equity ratio is also negative, reflecting the company's reliance on debt financing. Overall, the balance sheet indicates financial instability.
Cash Flow
40
Negative
Cash flow analysis shows mixed results. Operating cash flow has been negative in recent periods, and free cash flow has also been negative, indicating cash flow challenges. The free cash flow growth rate is highly volatile, and the operating cash flow to net income ratio is negative, suggesting inefficiencies in converting income to cash. The company needs to improve its cash flow management to ensure sustainability.
BreakdownTTMMar 2025Sep 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue29.50M38.90M56.20M73.10M82.50M85.80M
Gross Profit11.80M14.80M19.60M20.90M27.60M22.50M
EBITDA15.10M16.40M7.50M6.90M15.80M-10.50M
Net Income6.30M6.20M3.30M-100.00K12.10M-21.50M
Balance Sheet
Total Assets26.30M28.70M22.40M30.60M36.80M35.60M
Cash, Cash Equivalents and Short-Term Investments3.00M4.30M5.00M7.10M9.20M6.90M
Total Debt8.80M8.80M19.90M20.00M20.20M20.40M
Total Liabilities36.40M38.10M52.50M32.40M35.30M78.60M
Stockholders Equity-10.10M-9.40M-30.10M-1.80M1.50M-43.00M
Cash Flow
Free Cash Flow-2.60M-1.50M2.50M-800.00K2.70M-4.40M
Operating Cash Flow-2.60M-1.50M4.80M1.50M5.60M-4.00M
Investing Cash Flow15.50M14.80M-2.30M-2.30M-2.90M-400.00K
Financing Cash Flow-12.60M-14.00M-4.50M-1.20M-500.00K5.20M

Mothercare Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.19
Price Trends
50DMA
1.85
Negative
100DMA
2.16
Negative
200DMA
2.58
Negative
Market Momentum
MACD
-0.13
Positive
RSI
29.22
Positive
STOCH
1.98
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MTC, the sentiment is Negative. The current price of 2.19 is above the 20-day moving average (MA) of 1.73, above the 50-day MA of 1.85, and below the 200-day MA of 2.58, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 29.22 is Positive, neither overbought nor oversold. The STOCH value of 1.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:MTC.

Mothercare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
£482.37M11.707.52%13.21%-54.35%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
£27.50M-1.2063.25%-1.96%28.69%
60
Neutral
£14.00M-2.99-5.59%-1.65%-454.55%
60
Neutral
£523.29M1.55-35.25%-20.36%44.33%
56
Neutral
£660.05M8.84-113.93%1.40%3.94%
41
Neutral
£7.01M-2.53-64.62%-30.78%86.44%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:MTC
Mothercare
1.25
-1.48
-54.23%
GB:SOS
Sosandar PLC
6.25
-1.50
-19.35%
GB:AO
AO World
86.80
-9.20
-9.58%
GB:THG
THG
29.20
-4.80
-14.12%
GB:WRKS
TheWorks.co.uk plc
44.00
24.45
125.06%
GB:MOON
Moonpig Group Plc
213.00
15.97
8.11%

Mothercare Corporate Events

Regulatory Filings and Compliance
Mothercare Leaves SAYE Share Pool Unchanged in Latest Block Listing Update
Positive
Mar 13, 2026

Mothercare plc has reported its latest six‑monthly block listing update for shares reserved under its Save As You Earn (SAYE) employee share plans, covering the period from 13 September 2025 to 12 March 2026. The company confirmed that no new securities were issued or allotted under the SAYE schemes during the period, leaving the balance of unallotted shares unchanged at 23,356,329, a signal of stability in its employee equity participation structure.

The unchanged block listing position indicates that Mothercare has significant headroom remaining for future employee option exercises without needing to seek an increase in the scheme size. For stakeholders, this suggests no recent dilution from employee share issuance and preserves flexibility for future incentives, which can be important for staff retention and alignment with shareholder interests.

The most recent analyst rating on (GB:MTC) stock is a Sell with a £1.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Mothercare Secures High-Cost Refinancing and Extends Pension Deferrals to 2027
Positive
Feb 20, 2026

Mothercare has refinanced its existing debt by replacing an £8m facility with Gordon Brothers through a new special purpose vehicle backed by a consortium of investors, enlarging the facility to £8.46m at signing with scope to rise to £10m and extending maturity to December 2027. The amended facility, which carries a 25% annual coupon split between cash and payment-in-kind interest, remains technically in default and repayable on demand, but directors say the deal improves alignment between secured creditors and shareholders, even as Gordon Brothers is fully repaid and retains its warrants.

The company has also secured an extension to the deferral of annual pension deficit contributions of £3m per year to March 2027, pushing £6m of payments into a new schedule to be agreed by March 2027, with contributions resuming from April 2027 at an agreed affordable level. Chairman Clive Whiley said the combined refinancing and pension deferral ease material uncertainty, bolster liquidity, and provide flexibility to pursue international growth opportunities, underscoring management’s confidence that the strengthened capital structure can support a renewed push in both existing and new territories.

The most recent analyst rating on (GB:MTC) stock is a Sell with a £1.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 20, 2026